“The illiterate of the 21st century will not be those who cannot read and write,
but those who cannot learn, unlearn, and relearn.”
-Alvin Toffler
Monday, February 10, 2014
International Disaster Law Course 28 April - 2 May 2014, Sanremo, Italy
Saturday, February 8, 2014
Contingency Management in the NCR. Monday, May 12, 2014
the Joint Force Headquarters
Military District of Washington’s (JFHQ/MDW) 8th Annual Interagency
Chaplaincy Conference -which will be held on Monday, May 12, 2014 at the Spates
Club at Fort Myer. It will be a full days training and the topic will be
“Contingency Management in the NCR - How Do Civil Authorities and the Military
Work Together / What Does It Look Like”.
This is a very important regional topic and we look forward to once again
seeing everyone! Registration and additional information will SOON
follow.
____________________________________________________
SAVE THE DATE
Joint Force Headquarters Military District of
Washington (JFHQ/MDW)
8th Annual Interagency Chaplaincy Conference
-
Contingency
Management in the NCR -
How Do Civil
Authorities and the Military Work Together / What Does It Look Like
Spates Club at Fort Myer
Monday, May 12, 2014
SAVE THE DATE
Tuesday, February 4, 2014
Drug Manufacturing Shortages within the U.S. February 2014.
What's New on the FDA Drugs Site
February 3, 2014
- Current
Drug Shortages Index (updated)
- Drugs
to be Discontinued: Calcitriol Injection
- Resolved
Drug Shortages: Hydromorphone Hydrochloride Tablets
- Resolved
Drug Shortages: Isoniazid; Rifampin (Rifamate) Capsules
- Resolved
Drug Shortages: Levothyroxine sodium (Levoxyl) Tablets
- Drug
Firm Annual Registration Status (updated)
- Drug
Firm Annual Registration Status Download File (updated)
- FDA
approves Hetlioz (tasimelteon): first treatment for non-24 hour sleep-wake
disorder in blind individuals
- National
Drug Code Directory
January 31, 2014
Drug Name
|
Active Ingredient
|
Dosage Form/Route
|
Sponsor
|
Submission Type
|
corticorelin ovine triflutate
|
Injectable;Injection
|
Ferring
|
Manufacturing Change or Addition
|
|
atazanavir sulfate
|
Capsule; Oral
|
Aurobindo Pharma Ltd
|
Tentative Approval
|
|
fexofenadine hydrochloride
|
Tablet, Orally Disintegrating;Oral
|
Sanofi Aventis Us
|
Manufacturing Change or Addition
|
|
fexofenadine hydrochloride
|
Tablet, Orally Disintegrating;Oral
|
Sanofi Aventis Us
|
Manufacturing Change or Addition
|
|
metformin hydrochloride
|
Tablet, Extended Release;Oral
|
Bristol Myers Squibb
|
Manufacturing Change or Addition
|
|
tasimelteon
|
Capsule; Oral
|
Vanda Pharmaceuticals Inc
|
Approval
|
|
insulin lispro recombinant
|
Injectable;Injection
|
Lilly
|
Manufacturing Change or Addition
|
|
insulin lispro recombinant
|
Injectable;Injection
|
Lilly
|
Manufacturing Change or Addition
|
|
insulin lispro recombinant
|
Injectable;Injection
|
Lilly
|
Manufacturing Change or Addition
|
|
carfilzomib
|
Powder;Intravenous
|
Onyx Pharms
|
Manufacturing Change or Addition
|
|
ambrisentan
|
Tablet;Oral
|
Gilead
|
Labeling Revision
|
|
oxycodone hydrochloride
|
Tablet, Extended Release;Oral
|
Purdue Pharma Lp
|
Manufacturing Change or Addition
|
|
finasteride
|
Tablet;Oral
|
Merck
|
Labeling Revision
|
|
urea, c-14
|
Capsule;Oral
|
Avent
|
Manufacturing Change or Addition
|
|
urea, c-14
|
Capsule;Oral
|
Avent
|
Manufacturing Change or Addition
|
|
sildenafil citrate
|
Tablet;Oral
|
Pfizer
|
Efficacy Supplement with Clinical Data to Support
|
|
sildenafil citrate
|
Tablet;Oral
|
Pfizer
|
Labeling Revision
|
|
sildenafil citrate
|
Solution;Intravenous
|
Pfizer
|
Efficacy Supplement with Clinical Data to Support
|
|
sildenafil citrate
|
Solution;Intravenous
|
Pfizer
|
Labeling Revision
|
|
sildenafil citrate
|
For Suspension;Oral
|
Pfizer
|
Efficacy Supplement with Clinical Data to Support
|
|
sildenafil citrate
|
For Suspension;Oral
|
Pfizer
|
Labeling Revision
|
|
menthol; methyl salicylate
|
Patch;Topical
|
Hisamitsu Pharm Co
|
Manufacturing Change or Addition
|
|
articaine hydrochloride; epinephrine bitartrate
|
Injectable;Injection
|
Deproco
|
Manufacturing Change or Addition
|
|
ciclesonide
|
Aerosol, Metered;Nasal
|
Takeda Gmbh
|
Manufacturing Change or Addition
|
Affordable Care Act for Individuals and Small Businesses. Webinar: February & March 2014
|
Subscribe to:
Comments (Atom)
Popular Posts
-
"You have to act as if it were possible to radically transform the world. And you have to do it all the time.” —Angela Davis Even wit...
-
https://www.differencebetween.com/difference-between-anthropocentrism-biocentrism-and-ecocentrism/ Difference Between Anthropocentrism Bi...
-
https://bawza.com/2013/12/12/early-ethiopians-in-america/ History Early Ethiopians in America By Bawza Staff ...